ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
163 hedge funds and large institutions have $451M invested in Acorda Therapeutics in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 80 increasing their positions, 39 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
51% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 35
Holders
163
Holding in Top 10
–
Calls
$1.82M
Puts
$1.21M
Top Buyers
| 1 | +$13.2M | |
| 2 | +$8.65M | |
| 3 | +$4.19M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$2.3M |
Top Sellers
| 1 | -$8.72M | |
| 2 | -$6.55M | |
| 3 | -$5.19M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.61M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.52M |